Role of lipid polymorphism in pulmonary surfactant

被引:68
作者
Perkins, WR
Dause, RB
Parente, RA
Minchey, SR
Neuman, KC
Gruner, SM
Taraschi, TF
Janoff, AS
机构
[1] LIPOSOME CO INC, PRINCETON, NJ 08540 USA
[2] PRINCETON UNIV, DEPT PHYS, PRINCETON, NJ 08544 USA
[3] THOMAS JEFFERSON UNIV, DEPT PATHOL & CELL BIOL, PHILADELPHIA, PA 19107 USA
关键词
D O I
10.1126/science.273.5273.330
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The development of artificial surfactants for the treatment of respiratory distress syndrome (RDS) requires lipid systems that can spread rapidly from solution to the air-water interface, Because hydration-repulsion forces stabilize liposomal bilayers and oppose spreading, liposome systems that undergo geometric rearrangement from the bilayer (lamellar) phase to the hexagonal II (H-II) phase could hasten lipid transfer to the air-water interface through unstable transition intermediates. A liposome system containing dipalmitoylphosphatidylcholine was designed; the system is stable at 23 degrees C but undergoes transformation to the H-II phase as the temperature increases to 37 degrees C. The spreading of lipid from this system to the air-water interface was rapid at 37 degrees C but slow at 23 degrees C, When tested in vivo in a neonatal rabbit model, such systems elicited an onset of action equal to that of native human surfactant. These findings suggest that lipid polymorphic phase behavior may have a crucial role in the effective functioning of pulmonary surfactant.
引用
收藏
页码:330 / 332
页数:3
相关论文
共 40 条
[21]  
JANOFF AS, 1992, Patent No. 6703
[22]   PROGNOSTIC VALUE OF THE IMMEDIATE RESPONSE TO SURFACTANT [J].
KUINT, J ;
REICHMAN, B ;
NEUMANN, L ;
SHINWELL, ES .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1994, 71 (03) :F170-F173
[23]   UNIFORM PREPARATIONS OF LARGE UNILAMELLAR VESICLES CONTAINING ANIONIC LIPIDS [J].
LI, W ;
HAINES, TH .
BIOCHEMISTRY, 1986, 25 (23) :7477-7483
[24]  
MARSH D, 1990, HDB LIPID BILAYERS, P265
[25]   HEAD GROUP MODULATION OF MEMBRANE FLUIDITY IN SONICATED PHOSPHOLIPID DISPERSIONS [J].
MICHAELSON, DM ;
HORWITZ, AF ;
KLEIN, MP .
BIOCHEMISTRY, 1974, 13 (12) :2605-2612
[26]   PROPHYLACTIC TREATMENT OF PREMATURE BABIES WITH ARTIFICIAL SURFACTANT (ALEC) [J].
MORLEY, CJ .
DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1989, 13 (2-4) :182-183
[27]   RESPIRATORY COMPLIANCE IN PREMATURE BABIES TREATED WITH ARTIFICIAL SURFACTANT (ALEC) [J].
MORLEY, CJ ;
GREENOUGH, A .
ARCHIVES OF DISEASE IN CHILDHOOD, 1991, 66 (04) :467-471
[28]   RANDOMIZED TRIAL OF ARTIFICIAL SURFACTANT (ALEC) GIVEN AT BIRTH TO BABIES FROM 23 TO 34 WEEKS GESTATION [J].
MORLEY, CJ ;
GREENOUGH, A ;
MILLER, NG ;
BANGHAM, AD ;
POOL, J ;
WOOD, S ;
SOUTH, M ;
DAVIS, JA ;
VYAS, H .
EARLY HUMAN DEVELOPMENT, 1988, 17 (01) :41-54
[29]   FOLLOW-UP OF PREMATURE BABIES TREATED WITH ARTIFICIAL SURFACTANT (ALEC) [J].
MORLEY, CJ ;
MORLEY, R .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1990, 65 (07) :667-669
[30]   SURFACTANT PROTEIN-A AND SATURATED PHOSPHATIDYLCHOLINE IN RESPIRATORY-DISTRESS SYNDROME [J].
MOYA, FR ;
MONTES, HF ;
THOMAS, VL ;
MOUZINHO, AM ;
SMITH, JF ;
ROSENFELD, CR .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (06) :1672-1677